[Treatment of neurologic diseases with synthetic corticotropin (beta-1-24-corticotropin)].
D000238:Adenoma, Chromophobe / Q000188:drug therapy; D000293:Adolescent; D000311:Adrenal Glands / Q000187:drug effects; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D003882:Dermatomyositis / Q000188:drug therapy; D004679:Encephalomyelitis / Q000188:drug therapy*; D004827:Epilepsy / Q000188:drug therapy; D005158:Facial Paralysis / Q000188:drug therapy; D005260:Female; D013700:Giant Cell Arteritis / Q000188:drug therapy; D006563:Herpes Zoster Ophthalmicus / Q000188:drug therapy; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy; D009103:Multiple Sclerosis / Q000188:drug therapy*; D009133:Muscular Atrophy / Q000188:drug therapy; D009136:Muscular Dystrophies / Q000188:drug therapy; D009157:Myasthenia Gravis / Q000188:drug therapy; D009187:Myelitis / Q000188:drug therapy; D009220:Myositis / Q000188:drug therapy; D009422:Nervous System Diseases / Q000188:drug therapy*; D009437:Neuralgia / Q000188:drug therapy; D009443:Neuritis / Q000188:drug therapy*; D010911:Pituitary Neoplasms / Q000188:drug therapy; D013122:Spinal Diseases / Q000188:drug therapy; D014277:Trigeminal Neuralgia / Q000188:drug therapy
D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone
Zur Behandlung neurologischer Erkrankungen mit synthetischem Kortikotropin (beta-1-24-Corticotropin)